Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
- 30 June 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (6), 561-570
- https://doi.org/10.1016/s1470-2045(10)70071-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literatureAnnals of Oncology, 2009
- Hyperthermia adds to chemotherapyEuropean Journal of Cancer, 2008
- Preoperative Chemotherapy and Split-Course Radiation Therapy for Patients With Localized Soft Tissue Sarcomas: Home Run, Base Hit, or Strike Out?Journal of Clinical Oncology, 2006
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomasCancer, 2002
- Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue SarcomasJournal of Clinical Oncology, 2002
- Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II studyEuropean Journal of Cancer, 2001
- A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcomaEuropean Journal of Cancer, 2001
- Esho Quality Assurance Guidelines for Regional HyperthermiaInternational Journal of Hyperthermia, 1998
- Local hyperthermia enhances cyclophosphamide, ifosfamide andcis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude miceZeitschrift für Krebsforschung und Klinische Onkologie, 1992